CION Ameerpet
Skull base tumours sit in a crowded, delicate spot beneath the brain. Most are benign. We help you understand your scan, the type of tumour, and the safest next step.
A skull base tumour is a growth that develops in the bony floor of the skull — the crowded platform that sits directly beneath the brain. This is one of the most complex regions in the whole body: the brain rests on top of it, and the major nerves and large blood vessels that supply the head and face pass through small openings in the bone here. Everything is packed tightly together.
That location is what makes these tumours unique. Even a small skull base tumour can press on a nerve controlling vision, hearing, facial movement, or swallowing — so it can cause symptoms while still being tiny. Reassuringly, most skull base tumours are benign (non-cancerous), including common types such as meningiomas and pituitary adenomas. This page is an overview of the skull base tumour types, their symptoms, how they are diagnosed, and how they are treated as part of CION's brain tumour programme.
The great majority of skull base tumours are benign — meningiomas and pituitary adenomas together account for a large share, and meningiomas alone make up roughly one-third of all primary brain and central nervous system tumours (source: WHO Classification of Tumours of the Central Nervous System, 2021; NCCN Central Nervous System Cancers Guidelines). With skull base tumours it is usually the location, not whether the tumour is cancer, that makes treatment challenging.
Many different tumours can arise in or reach the skull base. Most are benign; a minority are malignant. Knowing the type is what decides how it behaves and how it is treated. Below are the ones seen most often.
The most common skull base tumour. It arises from the meninges — the membranes covering the brain — and is usually benign and slow-growing. Many small skull base meningiomas are simply monitored. Learn more on our meningioma page.
Arises from the pituitary gland at the centre of the skull base. Almost always benign. It can cause symptoms by pressing on the vision nerves or by over-producing hormones. See our pituitary adenoma page.
A benign tumour on the hearing and balance nerve. It typically causes gradual, one-sided hearing loss, ringing in the ear, and balance problems. Often managed by observation, radiosurgery, or surgery.
Rare bone tumours that grow from the base of the skull. These are considered malignant (low- to intermediate-grade cancers). They tend to grow slowly but can be locally invasive, and usually need surgery plus specialised radiation.
Cancers of the nose and sinuses can extend upward to reach the skull base, and rarely cancer from elsewhere spreads here (metastasis). These are malignant and treated with a combination of surgery, radiation, and systemic therapy.
Mostly benign growths near the pituitary and base of the brain. They can press on vision nerves and disrupt hormones, and are usually treated with coordinated surgery and, when needed, radiation.
Only tissue examined under a microscope confirms the exact type and whether a tumour is benign or malignant. That is why an accurate diagnosis comes first — before any treatment decision.
Because the skull base is so crowded, symptoms depend entirely on where a tumour sits and which nerve or structure it presses on. Many small skull base tumours cause no symptoms at all and are found by chance on a scan done for another reason. And when symptoms do appear, they overlap heavily with very common, harmless problems — an ear infection, a sinus issue, migraine, or simply ageing eyes and ears. Most people with these symptoms do not have a tumour.
What matters is a symptom that is new, one-sided, persistent, and slowly getting worse. Signs worth checking include:
Reassurance and a red flag together: occasional dizziness or a blocked nose is almost never a tumour. But new, one-sided hearing loss, progressive facial numbness, or double vision that does not resolve should be checked with a specialist and usually an MRI. Speak to a CION specialist if these describe you or someone you love.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether it was a surprise finding or you have symptoms, our neuro-oncology team will explain your options — monitoring, coordinated surgery, or radiosurgery — in plain language.
Getting the diagnosis right matters more here than almost anywhere, because the treatment for a benign meningioma is completely different from that for a chordoma or a sinonasal cancer. Diagnosis combines detailed imaging with targeted tests based on the suspected type:
At CION, your imaging and any reports are reviewed by a multidisciplinary neuro-oncology tumour board before any recommendation is made — so the advice reflects surgical, radiation, and medical oncology perspectives together, and molecular testing is arranged whenever it will genuinely change the plan.
International guidelines (NCCN Central Nervous System Cancers; European Association of Neuro-Oncology, EANO) support active surveillance — watching a small, symptom-free benign skull base tumour with periodic MRI rather than treating it straight away. Many people live for years with a stable skull base tumour that never needs an operation, which is why an accurate diagnosis and a specialist opinion come before any decision to treat.
There is no single "right" treatment for every skull base tumour. The best choice depends on the tumour's type, size, and exact location, whether it is benign or malignant, your symptoms, your age, and your overall health. The main options are:
For a small, benign skull base tumour that is not causing symptoms, the safest step is often to watch it with repeat MRI scans over time. Many benign tumours grow so slowly that they never need treatment — and this avoids the risks of surgery or radiation when they are not necessary.
Skull base surgery removes a tumour from the deep floor of the skull. Modern techniques have made it far safer than in the past: many tumours are now reached through endoscopic endonasal surgery — going through the nostrils with no external incision — while others need open microsurgery. Because this area contains vision, hearing, facial, and swallowing nerves plus major arteries, these operations are performed by dedicated skull base teams (neurosurgeons working alongside ENT surgeons). CION's panel does not include a neurosurgeon, so all skull base surgery is coordinated with accredited neurosurgical and ENT skull base partners. Our team plans the case with them, manages your medical and supportive care throughout, and arranges pathology and follow-up.
Stereotactic radiosurgery delivers finely focused radiation to the tumour without any incision — useful for smaller tumours, tumours in hard-to-reach spots, acoustic neuromas, or any tumour left behind after surgery. Larger or malignant tumours may instead receive fractionated radiation therapy (small daily doses over several weeks). CION delivers precision radiation (IMRT/IGRT) directly and coordinates specialist radiosurgery as part of your plan.
For most people with a benign skull base tumour, the outlook is reassuring. When a benign tumour is completely removed or well controlled, many people return to normal life, and long-term MRI follow-up is standard so any change is caught early. Recovery from skull base surgery focuses on protecting the nerves nearby — vision, hearing, facial movement, and swallowing — which is exactly why an experienced, coordinated team matters so much.
Malignant skull base tumours — such as chordomas, chondrosarcomas, and sinonasal cancers — are managed with a combination of coordinated surgery, specialised radiation, and systemic therapy, with closer monitoring afterwards. Whatever the type, your care is built around your specific tumour as part of CION's wider brain tumour treatment programme in Hyderabad.
When to get a second opinion: a skull base tumour diagnosis rarely needs to be treated as an emergency, which makes it an ideal moment to pause and get a second opinion — especially before agreeing to surgery, or if you have been told to "just monitor" but feel unsure. Bring your MRI and any reports and request a free written second opinion, or call 18002028726 to talk it through.
Get a free written second opinion from CION's neuro-oncology tumour board — especially helpful before deciding on skull base surgery.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.A skull base tumour is a growth that develops in the bony floor of the skull — the crowded area beneath the brain where the brain, spinal cord, major nerves, and large blood vessels all pass through. Because so many critical structures are packed into a small space, even a small tumour here can press on nerves controlling vision, hearing, facial movement, or swallowing. Most skull base tumours are benign (non-cancerous), such as meningiomas and pituitary adenomas, though some are malignant. The location — not whether it is cancer — is often what makes these tumours challenging to treat.
Most skull base tumours are not cancer. The commonest types — meningiomas, pituitary adenomas, and acoustic neuromas (vestibular schwannomas) — are usually benign and slow-growing. A minority are malignant, including chordomas, chondrosarcomas, cancers that have spread from elsewhere (metastases), and some sinonasal cancers that reach the skull base. Whether a tumour is benign or malignant is confirmed only by examining tissue under a microscope. Even benign skull base tumours are taken seriously, because their location near vital nerves and blood vessels can cause real symptoms and needs careful, coordinated care.
Symptoms depend entirely on where in the skull base the tumour sits and which nerve or structure it presses on. Common signs include hearing loss or ringing in one ear, double or blurred vision, facial numbness, weakness, or pain, a blocked nose or reduced sense of smell, dizziness or balance problems, or difficulty swallowing. Because these overlap with very common everyday problems, most people with them do not have a tumour. What matters is a symptom that is new, one-sided, persistent, and slowly getting worse — that pattern deserves a specialist review and usually an MRI.
There is no single treatment for every skull base tumour. Small, symptom-free benign tumours may simply be watched with periodic MRI. When treatment is needed, options include skull base surgery — often minimally invasive endoscopic surgery through the nose, or open microsurgery — and stereotactic radiosurgery for smaller or hard-to-reach tumours. CION's panel does not include a neurosurgeon, so all skull base surgery is coordinated with accredited neurosurgical and ENT skull base partners. CION delivers your imaging, diagnosis, precision radiation (IMRT/IGRT), hormone and medical management, and supportive care directly, and reviews every case at a multidisciplinary tumour board.
Skull base surgery is specialised surgery to remove a tumour from the deep, crowded floor of the skull. Modern techniques have made it far safer than in the past. Many tumours are now removed through endoscopic endonasal surgery — reaching the tumour through the nostrils with no external incision — while others need open microsurgery. Because the area contains vision, hearing, facial, and swallowing nerves plus major arteries, these operations are complex and are performed by dedicated skull base teams (neurosurgeons working with ENT surgeons). At CION this surgery is coordinated with accredited skull base partners, with our oncology team managing diagnosis, radiation, and follow-up around it.
Diagnosis begins with detailed imaging — an MRI of the brain and skull base with contrast to show the tumour and its relationship to nerves and blood vessels, often with a CT scan to show the surrounding bone. Depending on the suspected type, hormone blood tests (for pituitary tumours) or a hearing test (for acoustic neuromas) may be added. The definitive diagnosis and whether a tumour is benign or malignant is confirmed on tissue, usually obtained at surgery. At CION, imaging and reports are reviewed by a multidisciplinary neuro-oncology tumour board before any recommendation, so the plan reflects surgical, radiation, and medical oncology views together.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.